With 28.06 million shares changed hands, the volume of the stock remained heavier than its average volume of 26.65 million shares. During the session, the Capital Markets company that operates in wider Financial sector, reached to the highest price of $9.71 whereas the lowest price it dropped to was $9.11. The 52-week range on CLSK shows that it touched its highest point at $20.64 and its lowest point at $6.45 during that stretch. It currently has a 1-year price target of $20.00. Beta for the stock currently stands at 4.24.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CLSK was down-trending over the past week, with a drop of -5.01%, but this was down by -3.23% over a month. Three-month performance surged to 16.69% while six-month performance fell -28.13%. The stock lost -40.76% in the past year, while it has gained 0.98% so far this year. A look at the trailing 12-month EPS for CLSK yields -0.93 with Next year EPS estimates of 0.72. For the next quarter, that number is 0.14. This implies an EPS growth rate of 185.82% for this year and 21.28% for next year.
Float and Shares Shorts:
At present, 280.90 million CLSK shares are outstanding with a float of 272.89 million shares on hand for trading. On 2025-05-30, short shares totaled 72.21 million, which was 2570.0 higher than short shares on 1745971200. In addition to Mr. S. Matthew Schultz as the firm’s Executive Chairman, Mr. Zachary K. Bradford CPA serves as its CEO, President & Director.
Institutional Ownership:
Through their ownership of 0.63133 of CLSK’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-03-31, CLSK reported revenue of $181712000.0 and operating income of -$12587000.0. The EBITDA in the recently reported quarter was -$59156000.0 and diluted EPS was -$0.49.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CLSK since 4 analysts follow the stock currently. There are 4 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With CLSK analysts setting a high price target of 25.0 and a low target of 14.0, the average target price over the next 12 months is 19.44444. Based on these targets, CLSK could surge 168.82% to reach the target high and rise by 50.54% to reach the target low. Reaching the average price target will result in a growth of 109.08% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.35874 being high and -$0.54754 being low. For CLSK, this leads to a yearly average estimate of -$0.42404.
